Aclarion (ACONW) Amortization of Deferred Charges (2023 - 2024)

Aclarion (ACONW) reported Amortization of Deferred Charges of -$31129.0 for Q4 2024, down 109.12% on a YoY basis from $341497.0 in Q1 2024, and down 380.16% quarter-over-quarter from $11111.0 in Q3 2024.

Aclarion (ACONW) Amortization of Deferred Charges (2023 - 2024) Analysis & Trends

Aclarion has reported Amortization of Deferred Charges for 2 years, with the latest figure at -$31129.0 in Q4 2024.

  • For the quarter ending Q4 2024, Amortization of Deferred Charges fell 109.12% year-over-year to -$31129.0; the trailing twelve-month figure through Sep 2025 stood at -$31129.0 (down 103.69% YoY), and the FY2024 full-year result was $471387.0, down 5.28% from the prior year.
  • Amortization of Deferred Charges for Q4 2024 stood at -$31129.0, down from $11111.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $341497.0 in Q4 2023, with the low at -$31129.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn
10 Aclarion - - 3,750.00

Historic Data

Download Data
DateValue
Dec 31, 2024 -31,129.00
Dec 31, 2024 -31,129.00
Sep 30, 2024 11,111.00
Sep 30, 2024 11,111.00
Jun 30, 2024 156,053.00
Jun 30, 2024 156,053.00
Mar 31, 2024 335,352.00
Mar 31, 2024 335,352.00
Dec 31, 2023 341,497.00
Dec 31, 2023 341,497.00
Sep 30, 2023 127,639.00
Sep 30, 2023 127,639.00
Jun 30, 2023 28,520.00
Jun 30, 2023 28,520.00